Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
08/2008
08/14/2008US20080194459 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
08/14/2008US20080194445 Antioxidants for Synthetic Lubricants and Methods of Manufacture
08/13/2008EP1954668A2 Homo- and heterocyclic compounds suitable as cetp inhibitors
08/13/2008EP1581467A4 Ligands for metals and improved metal-catalyzed processes based thereon
08/13/2008CN101243043A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
08/13/2008CN101243039A Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
08/13/2008CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands
08/13/2008CN101239926A Method of preparing D-p-hydroxyphenylglycine
08/13/2008CN101239925A Method for preparing magnesium aspartate
08/13/2008CN101239924A Method for preparing functionality amino acid
08/13/2008CN101239923A Method for preparing (S,S)N-(1-ethoxycarbonyl-3-phenylpropyl)-L-amino acid derivatives and refining method thereof
08/13/2008CN101239922A Production technique of tert-butyl glycinate adapted for industrial production
08/13/2008CN101239915A Beta-elemene monosubstituted amine derivatives, synthetic method and use thereof
08/13/2008CN100410234C Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
08/12/2008US7411089 Dissolving in solvent in which nateglinide is highly soluble such as ethanol, dioxane, dichloromethane, or acetone; adding water or hexane in which nateglinide is not soluble; crystallization
08/12/2008US7411083 {[((1E)-{4-[3-(4-tert-butylphenoxy)prop-1-ynyl]phenyl}methylidene)amino]oxy}acetic acid; plasminogen activator inhibitor, anticoagulant; venous, arterial, cerebral, and deep vein thrombosis, atrial fibrillation, pulmonary fibrosis, myocardial ischemia, atherosclerotic plaque formation
08/12/2008US7410965 In a matrix-forming, hydrophilic or hydrophobic polymer comprising a cellulose ether or ester of hydroxypropyl methyl cellulose, hydroxyethycellulose, hydroxypropycellulos, methycellulose, ethycellulose and/or carboxymethyl cellulose
08/12/2008US7410622 Geometric stability of the thermoplate modules, particularly of the gaps for the catalyst; thermoplates configured with a cuboidal shape and installed with pressure release in a cylindrical shell which completely surrounds them
08/12/2008CA2350786C Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
08/07/2008WO2008094846A1 Reversible room-temperature ionic liquids
08/07/2008WO2008093686A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
08/07/2008US20080188672 Diamine substituted xanthene dyes having carboxylic acid functionality; hot melt or phase change inks; magenta; heat discoloration inhibition; hue, solubility, brilliance; color diffussion and leach resistance; durability even in warm climates; low cost; nonclogging
08/07/2008US20080188556 Nitrogen-containing esters of the secondary alcohol group of florfenicol and of its analogs,including salts; veterinary medicine; nonhydrolyzing as needed to maintain the prodrug in aqueous solution in the subjects system until appropriate; cattle drinking water; bovine respiratory disease
08/06/2008EP1951655A2 Amino acid derivatives
08/06/2008EP1404641B1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same
08/06/2008CN101234993A Method for preparing 5-aminoisophthalic acid from 5-nitroisophthalic acid
08/06/2008CN101234992A Method for preparing aspartic acid
08/06/2008CN100408643C Use of marine fungus originated compounds as antifouling agents
08/06/2008CN100408552C Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
08/05/2008US7408079 Imaging agents and methods of imaging NAALADase or PSMA
08/05/2008US7408078 Anthranilic acid derivatives useful in treating infection with hepatitis C virus
08/05/2008US7408076 2-Bromoanaline and 2-chloroaniline compounds
08/05/2008CA2314514C Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
07/2008
07/31/2008WO2008090073A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology
07/31/2008US20080183010 Reacting alpha -imino ester compound with phenyl-1-butyne to produce alkynylated alpha -amino esters; can be used to synthesize optically active unnatural alpha -amino acids
07/31/2008US20080182969 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
07/31/2008US20080182968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
07/31/2008US20080178763 exhibit high fluorescence in inks; useful for security taggant applications
07/31/2008CA2674568A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology
07/30/2008EP1948713A2 Functionalized amino acids and absorbable polymers therefrom
07/30/2008EP1948590A1 Process for the preparation of contrast agents
07/30/2008CN101233117A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
07/30/2008CN101233099A Process for production of mono-substituted alkylated compound using aldimine or derivative thereof
07/30/2008CN101231133A Flash drying method for D-dihydrobenzene glycine methyl dang sodium salt semifinished product
07/30/2008CN101230014A Utilization method of ammonia distillation cooling capacity in production of D-dihydrobenzene glycine methyl dane salt
07/30/2008CN101230013A Method for preparing enamine derivates
07/30/2008CN101230012A Extractive separation method of cicadae flower immunological suppression active effective part ISP extracts
07/30/2008CN100406449C CDC25 phosphatase inhibitors
07/30/2008CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications
07/30/2008CN100405910C Insecticide and method of controlling insects
07/29/2008US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies
07/29/2008US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
07/29/2008CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/29/2008CA2214323C Compounds and compositions for delivering active agents
07/29/2008CA2203033C Compounds and compositions for delivering active agents
07/24/2008WO2008086661A1 A process for synthesizing novel side chain of taxol or docetaxel and its derivatives
07/24/2008WO2008086595A1 Process for manufacturing hydrogen and monosodium glutamate
07/24/2008WO2008067257A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
07/24/2008US20080177103 tri- and tetracarboxylic acid esters of aminopolyethers; for inhibiting nucleation, growth, and/or agglomeration of gas hydrates; adding inhibitor which contains substituted polyesters to multiphase mixture tending to form hydrates and consisting of water, gas and optionally condensate
07/24/2008US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
07/24/2008US20080177027 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
07/24/2008US20080176952 Management of Ophthalmologic Disorders, Including Macular Degeneration
07/24/2008US20080176898 Leukotriene antagonists; cardiovascular disorders like unstable angina pectoris or myocardial infarction; Methyl 1-{[5-(ethoxycarbonyl)-2-(3-{4-[(4-isopropoxybenzyl)oxy]phenyl}propoxy)phenyl]-acetyl}piperidine-4-carboxylate
07/24/2008US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation
07/23/2008CN101225051A Preparation method of zinc glycinate
07/23/2008CN101225050A Preparation method of calcium glycine
07/23/2008CN101225049A Beta-elemene amino acid derivatives as well as synthetic method and use thereof
07/23/2008CN100404498C Process for separation and extraction of L-glutamine-15N2
07/22/2008US7402695 desalting step of removing a salt contained in the aqueous solution and/or formed in the neutralization step, and a step of separately collecting the optically active amino acid amide/amino acid separately from the desalted aqueous solution by a process which takes advantage of a difference in solubility
07/22/2008US7402692 Intermediates in producing phenoxyacetic acid derivatives and method of using the same
07/22/2008CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
07/22/2008CA2343346C Process for the preparation of 4,5-diamino shikimic acid derivatives
07/22/2008CA2268411C Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
07/22/2008CA2195635C Process for the preparation of a halosubstituted aromatic acid
07/17/2008WO2008083967A2 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
07/17/2008WO2008083543A1 Nitrogen-containing heterocyclic modified compounds and uses thereof
07/17/2008WO2007121312A9 Trivalent chromium compounds, compositions and methods of use
07/17/2008US20080171874 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
07/17/2008US20080171789 Catechol protected levodopa diester prodrugs, compositions, and methods of use
07/17/2008US20080171671 Use of Ethoxylated Amidoamines as Emulsifiers in Drilling Fluids
07/17/2008CA2674291A1 New process
07/16/2008EP1942899A2 Mitotic kinesin inhibitors
07/16/2008EP1747190B1 Process for the preparation of valsartan and precursors thereof
07/16/2008EP1381597B1 Process for preparing hydroxyethylamines
07/16/2008CN101219964A Process for producing 5-ammonia-2-bromine benzoic acid
07/16/2008CN101219963A Phenylcarbinol kearny ester compounds
07/16/2008CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands
07/16/2008CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
07/15/2008US7399884 Substituted benzamides; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008CA2476022C A process for preparing a phenylalanine derivative and intermediates thereof
07/10/2008WO2008082486A2 Preparation of 3-amino-3-(cyclobutylmethyl)-2-(hydroxy)-propionamide hydrochloride
07/10/2008WO2008080287A1 L-carnitine calcium fumarate, preparation method and application for the same
07/10/2008WO2008062469A3 Selective tr-beta 1 agonist
07/10/2008US20080167377 Novel compounds
07/10/2008US20080163790 Dispersants
07/10/2008CA2672570A1 Preparation of 3-amino-3-(cyclobutylmethyl)-2-(hydroxy)-propionamide hydrochloride
07/09/2008EP1940808A1 Difluorophenol derivatives and their use
07/09/2008EP1940774A1 New synthesis of substituted hydroxymethyl phenols
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 215